-
UnitedHealth Group shareholders reject health equity audit, political lobbying proposals
In a wide margin, UnitedHealth Group shareholders have rejected three proposals that revolved around health equity efforts, political donations and how much severance executives receive when they leave the company, according to regulatory filings published June 9. -
10 Medicare Advantage updates from the first half of 2023
CMS implemented several policy changes for Medicare Advantage plans in the first half of 2023, including adjusting payment rates and implementing stricter audits. -
Medicare Part D prescription drug caps could slow healthcare costs
Copay caps on prescription drug costs could slow the growth of retirees' expected healthcare costs, a report from Fidelity found. -
Why North Carolina's Medicaid expansion could raise hospital prices
The way North Carolina's Medicaid expansion is financed could incentivize hospitals to increase prices, experts wrote in an article published June 21 in Health Affairs. -
BCBS Minnesota adding mental health peer support coverage for commercial plans
Blue Cross and Blue Shield of Minnesota said access to peer support specialists will be a covered benefit for fully insured commercial plan members starting in 2024. -
How Mark Cuban's Cost Plus Drugs has been turned into an insurance benefit
Mark Cuban Cost Plus Drug Co. is most known for selling cheap prescription drugs directly to consumers through the mail, but those cheap prices have been turned into a benefits solution for health plans. -
Administrative costs for BCBS plans on the rise: 5 things to know
Administrative costs for Blue Cross Blue Shield plans rose in 2022, according to an analysis from Sherlock Company. -
Georgia's Medicaid work requirements could be 'great opportunity for other states,' lawmaker says
Georgia's Medicaid work requirement program is set to take effect July 1, and it could serve as a model for other states, Politico reported June 20. -
Ozempic manufacturer continues lobbying push for Medicare coverage of weight loss drugs
Novo Nordisk, which manufactures Ozempic and Wegovy, has hired a lobbying firm to convince Congress to allow Medicare to cover the drugs for weight loss, Politico reported June 16. -
Aetna in the headlines: 7 recent updates
Aetna is defending a Medicare Advantage plan for retired New York City employees in court, and parent company CVS Health is sparring with Cigna over an executive's noncompete agreement. -
Medicare spending growth will take off in 2023, CMS projects
Medicare spending will grow by 8 percent in 2023, driven by higher hospital utilization and enrollment, CMS projects. -
Medicare Advantage in the headlines: 7 recent updates
Aetna is seeking to defend a contract to provide a Medicare Advantage plan for New York City's retired employees in court, and new research finds overpayments in the program could be larger than previously thought. -
Supreme Court allows Justice Department to dismiss whistleblower lawsuit against UnitedHealth Group
The Supreme Court upheld the Justice Department's decision to dismiss a whistleblower lawsuit alleging a UnitedHealth Group subsidiary overcharged Medicare. -
Aetna Medicare Advantage plan moving ahead, NYC mayor says
New York City Mayor Eric Adams is overriding the city comptroller's attempt to block the implementation of its contract with Aetna to administer a Medicare Advantage plan for 250,000 city retirees. -
50 things to know about CVS Health
CVS Health has grown from a single store to a healthcare giant, operating pharmacies, a major insurer and primary and home care clinics. -
California fines Kaiser Permanente health plan for violating enrollee confidentiality
California's Department of Managed Healthcare has fined Kaiser Permanente $450,000 for sending mailings with enrollees' private health information to incorrect addresses. -
Humana joins UnitedHealth in rising medical cost warning
Humana is anticipating its medical loss ratio will be at the top end of its full-year projected range of 86.3 percent to 87.3 percent, according to a June 16 SEC filing. -
Alliance of Community Health Plans pitches cap on Medicare Advantage marketing spending, broker payments
The Alliance of Community Health Plans is proposing a set of policies aimed at curbing misleading marketing in Medicare Advantage. -
How CVS, Walgreens are the front door to Medicaid redeterminations
The nation's retail pharmacy giants are playing an important role in Medicaid redeterminations through payer-agnostic outreach and education initiatives aimed at customers and employees in all 50 states. -
What 9 leaders are saying about Medicaid coverage losses
More than 1 million people have been disenrolled from Medicaid coverage, according to June 12 data from KFF.
Page 48 of 50